MedPath

Comparison Between Deep Sclerectomy and Traditional Trabeculotomy & Trabeculectomy in Congenital Glaucoma

Phase 1
Conditions
Congenital Glaucoma
Registration Number
NCT01460017
Lead Sponsor
King Saud University
Brief Summary

The investigators hypothesize that deep sclerectomy in congenital glaucoma is a safer procedure and may yield better results than trabeculotomy trabeculectomy approach.

Detailed Description

Non penetrating glaucoma surgery depends on filtration through trabeculo-descmeto window as well as supra-choroidal space less to sub-conjunctival rout. the nature of the operation keeps the globe intact without penetration that leads to less complications compared to penetrating trabeculectomy combined with trabeculotomy.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Any case diagnosed as congenital glaucoma with enlarged corneal diameter more than 11 mm and intra-ocular pressure above 21 mmHg, including corneal edema or Habb's Stria with or without optic disc cupping.
  • Any case diagnosed as primary or secondary congenital glaucoma to ocular or systemic abnormalities.
  • Within the age of (0 - 12).
Exclusion Criteria
  • Cases of congenital glaucoma with previous intervention.
  • Age above 12 Yrs.
  • Cases with secondary glaucoma caused by surgical intervention, ocular co-morbidity, medications or trauma

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
reduction in IOP6 month

decrease in the intraocular pressure to the normal limit (\<22 - \>6) mmHg

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

King Abdul Aziz University Hospital

🇸🇦

Riyadh, Saudi Arabia

King Abdul Aziz University Hospital
🇸🇦Riyadh, Saudi Arabia
Saleh A. Al-Obeidan, MD
Contact
+96614786100
alobeidan@yahoo.com
Essam A. Osman, FRCS
Sub Investigator
Ahmed M Abdel-Rahim, Ph. D.
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.